Phenolic Compounds with Anti-virulence Properties by Muñoz-Cazares, Naybi et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 8
Phenolic Compounds with Anti-virulence Properties
Naybi Muñoz-Cazares, Rodolfo García-Contreras,
Macrina Pérez-López and Israel Castillo-Juárez
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/66367
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
Naybi Muñoz-Cazares, Rodolfo García-
Contreras, Macrin  Pérez-López and Israel 
Castillo-Juárez
Additional information is available at the end of the chapter
Abstract
Natural products represent the major source of approved drugs and still play an impor-
tant role in supplying chemical diversity as well as new structures for designing more 
efficient antimicrobials. They are also the basis for the discovery of new mechanisms of 
antibacterial action. In this regard, a large number of substances, mainly extracts from 
natural sources, have been obtained in order to identify their anti-virulence activity. In 
recent years, there is an increase in the study of anti-virulence natural product deriva-
tives. Different targets have been proposed as a solution to the serious problem of bacte-
rial antibiotic resistance. Inhibition of bacterial quorum-sensing systems has been one of 
the most studied; however, there are other mechanisms involved in virulence regulation, 
damage to the host and bacterial survival, which suggests that there are another good 
targets such as bacterial secretion systems, biofilm formation, two-component systems, 
flagellum, fimbriae, toxins and key enzymes. Within the natural products, the main 
anti-virulence compounds are phenolic in nature, so that the next chapter describes and 
analyzes the relationship between chemical structure and activity of the main phenolic 
compounds reported.
Keywords: anti-virulence, quorum sensing, antibiotic resistance, phytochemicals, 
antibiofilms
1. Introduction
Since their introduction in the middle forties, antibiotics had been extensively used for the 
treatment of infectious diseases, producing remarkable results and saving millions of lives 
worldwide [1]; nevertheless, bacteria are very dynamic organisms able to interchange 
genes by several mechanisms including conjugation, transformation and transfection via 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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 bacteriophages [1]. In addition, they usually replicate at high rates and hence have the abil-
ity to evolve quickly and adapt to strong selective pressures; this combined with the self-
prescription, inadequate prescription by some physicians (e.g., to treat viral diseases) and 
their improper use by patients who do not complete the recommended treatment scheme has 
derived in an alarming situation since to date antibiotic resistance (including multiresistance 
and panresistance) is a common trend in most of hospital-acquired infections and is becom-
ing more common in community-acquired ones [2, 3]. In fact, the situation is so delicate that 
recently, the OMS warned that if the current trends are still observed, then by the year 2050 
we will enter the post-antibiotic era and previously treatable infectious diseases will cause 
more deaths than other important diseases such as cancer [4].
Hence, the discovery of new antibiotics as well as the development of alternative approaches 
to combat bacterial infections is urgently needed [5]; among such new approaches are the 
inhibition of bacterial antibiotic resistance mechanisms, the utilization of non-antibiotic bac-
tericide agents such as bacteriophages, the repurposing of clinically approved drugs, and 
the inhibition of bacterial virulence [5]. For the first approach, already successful examples 
can be found in the clinic; by instance, the co-utilization of clavulanic acid (an inhibitor 
of β-lactamases) and amoxicillin is commonly administrated [6]; and current research is 
focused on the utilization of broad spectrum anti-resistance compounds such as those inhib-
iting multidrug efflux pumps [7]. Regarding the second approach, it was recently demon-
strated that some anticancer drugs such as 5-fluorouracil [8], mitomycin C [9] and cisplatin 
[10] have remarkable antibacterial properties, while bacteriophages had been used in east 
European countries for the treatment of diverse bacterial infections, and currently, its uti-
lization in the occidental medicine is being proposed [11, 12]. Finally, targeting bacterial 
virulence instead of their viability is a concept that had derived in several publications, 
mostly centered in the inhibition of master virulence regulators such as quorum-sensing 
(QS) systems, which allow several Gram-negative and Gram-positive bacteria to coordi-
nate the production of several virulence factors, once a high population density is reached 
(Figure 1A). Indeed, initially, it was claimed that this approach will be impervious to the 
generation of resistance since in vitro in rich media QS does not control metabolic processes 
linked to growth; nevertheless, in some conditions, QS inhibition can promote resistance 
[13–15] and not all clinical strains are sensitive toward current QS inhibitors [16]. However, 
since QS also regulates the stress response, it has been shown that QS-inhibited bacteria 
are more susceptible to the action of disinfectants, antibiotics and the immune system [17, 
18], and hence, QS inhibition may be a valuable adjuvant therapy for recalcitrant bacterial 
infections [15].
As mentioned previously, QS is a master regulator of the production of several bacterial 
virulence factors, such as: exoproteases that degrade connective tissue such as elastase and 
alkaline protease (collagenase), phenazines that promote the generation of reactive oxygen 
species, siderophores that facilitate iron uptake, toxins that disrupt cellular processes and 
exopolysaccharides that form phagocytosis-resistant capsules and participate in the genera-
tion of the biofilm matrix [19] (Figure 1C).
Another key factor for the development of chronic infections and colonization of surfaces 
is the formation of biofilms, which is the main way the bacteria are found in nature [20]. 
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These structures consist of multicellular communities enclosed in a matrix which makes them 
extremely resistant to antibacterial agents (Figure 1B) [21]. They also provide robust niches 
that allow the bacteria to protect themselves from environmental fluctuations and against the 
immune system, which drastically reduces the effectiveness of antimicrobial therapy [20].
Since for many pathogenic bacteria QS is the main regulator of expression of bacterial vir-
ulence factors [19], its disruption has been the main anti-virulence strategy investigated to 
date [19]. However, another alternative that has also been reported is the direct inhibition of 
individual virulence factors, such as toxins, response regulators (two-component regulatory 
systems (TCS) and processes involved in the formation and maturation of structures such as 
the curli, the bacterial type III secretion system (T3SS), fimbriae and flagellum.
TCS are response regulators which are formed by a protein localized in the cytoplasmic mem-
brane called histidine kinase sensory protein (HKSP), which acts as an environmental sensor 
that is activated in ATP-dependent way (Figure 1D) [22]. HKSP then activates a response 
regulator protein (RRP) found in the cytoplasm which is responsible for recognizing DNA 
sequences that modulate the expression of genes involved in various functions such as che-
motaxis, porin expression and expression of virulence factors among others (Figure 1D) [22]. 
An important feature is that TCRs have not detected in mammalian cells, so there are a suit-
able specific target to treat bacterial infections [23].
Figure 1. Main targets of anti-virulence of phenolic compounds. A: Quorum-sensing system, B: biofilm formation, C: 
toxins, D: two-component systems, E: curli fibers, F: bacterial type III secretion systems, G: flagellum, H: fimbriae, I: 
sortase enzymes.
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The curli (Figure 1E) is the major protein component of the extracellular matrix and is mainly 
produced by enterobacteria to aid in the formation of three-dimensional structures such as 
biofilms [24]. Curli fibers belong to a growing class of fibers known as amyloid fibers, which 
are also involved in host cell adhesion and invasion, and are also strong inducers of host 
inflammatory response [24]. The structure and biogenesis of curli are unique among bacterial 
fibers and represent an excellent anti-virulence target [25].
The type III secretion system (T3SS) also known as the injectisome is a multiprotein apparatus 
that facilitates the secretion and translocation of toxins or effector proteins from the bacte-
rial cytoplasm directly to eukaryotic cells (Figure 1F) [26, 27]. It is highly conserved in most 
Gram-negative pathogens, but its presence is not a necessary condition for bacterial survival 
in vitro [27].
Motility and recognition surfaces are key factors for the dispersal and colonization of new 
niches by bacteria [28]. For that, the flagellum and the fimbriae are target structures suit-
able for anti-virulence molecules [28, 29]. The flagella (Figure 1G) are multiprotein complexes 
based on flagellin, which rotate allowing bacterial displacement in aqueous media [29], while 
fimbriae (Figure 1H) are extracellular protein structures mainly constituted by pilin, which 
start in the plasma membrane, cross the cell wall and extend around the cell. These structures 
allow the adhesion of bacteria mainly to epithelial cells [30].
Another important virulence factors are the sortase enzymes (cysteine transpeptidases) 
(Figure 1I), which are used by Gram-positive bacteria to display proteins in cell surface, such 
as glycoproteins [30], and they can also attach to proteins in the cross-bridge peptide of the 
cell wall or link other proteins together to form pilin [31]. The phenomenon of protein deploy-
ment is essential for the development of virulence factors and promotes nutrient acquisi-
tion, adhesion and immune system evasion [30]. Because surface proteins play a fundamental 
role in microbial physiology and are frequently virulence factors, sortase enzymes are a very 
important target [31].
Reports related to the study of natural products as anti-virulence molecules had increased in 
the last decade. Their powerful attack against bacterial infections without promoting resis-
tance and the elimination of antibiotic-resistant strains are the most attractive features of this 
kind of compounds. Among natural products with anti-virulence activity, those derived from 
plants with anti-QS and antibiofilm activity are the most common [32]. Phenolic compounds 
are secondary metabolites present in plants, which are crucial in many aspects of their lives, 
especially during the interactions with the environment, since they are used in the defense 
of plants against bacterial pathogens. Similarly, compounds of phenolic type are the major 
metabolites with anti-virulence properties described so far, and specifically, the flavonoids 
are the main representatives [33].
Most of the biologically active reported phenolic compounds have chemical structures with 
previously identified antimicrobial, antioxidant and anticancer activity. Similarly, for some of 
them their participation in the regulation of various physiological functions in plants and ani-
mals is well known. In recent years, the anti-virulence properties of phenolic compounds are 
being unravel, and most of the cases depend on the compound concentration and the bacterial 
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system in which the phenolic compounds can exhibit bactericidal or anti-virulence effects. 
In the next chapter, we discuss studies of phenolic compounds derived mainly from plant 
species, starting with those that are better characterized and that have more anti-virulence 
reported properties. We focus on the relationship between their structures and their activity.
2. Phenolic compounds anti-virulence
2.1. Epigallocatechin gallate and related compounds
It is well documented that this kind of compounds has antimicrobial, antioxidant, anti-inflam-
matory, hypocholesterolemic and cancer-preventive properties [34, 35]. The epigallocatechin 
gallate (EGCG) (Figure 2A) is one of the flavonoids with the largest number of reports related 
to its antibiofilm activity; remarkably high compound doses can inhibit bacterial growth, but 
sublethal concentrations exhibit anti-virulence properties.
At the same concentration, catechin (Figure 2B) and EGCG inhibit the formation of biofilms of 
P. aeruginosa; however, only catechin do not affect the growth [36], so the presence of galloyl 
Figure 2. Epigallocatechin gallate and related compounds with anti-virulence properties. A: Epigallocatechin gallate, B: 
catechin, C: catechin-gallate, D: catechin-gallate, E: (−) epicatechin gallate.
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group in EGCG seems to favor the bactericidal effect. In this regard, it is suggested that EGCG 
affect the viability because it binds to peptidoglycan, hence directly disrupting the integrity of 
the bacterial cell wall. Similarly, EGCG at concentrations that affect bacterial viability inhibit 
the biofilm of Enterococcus faecalis, an opportunistic pathogen implicated in urinary tract infec-
tions, endocarditis and root canal infections [37]. In this case, biofilm inhibition is attributed 
to a bactericidal effect, where the EGCG induces hydroxyl radicals that can damage DNA, 
proteins and lipids [37].
However, using sublethal concentrations, it has been found that EGCG significantly decreased 
the expression of virulence genes that regulate the expression of cytolysins, gelatinase and 
serine protease in E. faecalis [37]. It also inhibits biofilm formation of Staphylococcal isolates by 
interfering directly with polysaccharides of the glycocalyx [38]. Similarly, it inhibits swarm-
ing and biofilm formation of Burkholderia cepacia without affecting the growth, likely through 
QS inhibition [39].
EGCG and catechin gallate (Figure 2C) directly inhibit the anthrax lethal factor (LF) produced 
by Bacillus anthracis, which has a key role in the development of anthrax [40]. LF is a zinc 
metalloprotease that directly affects MAPK-signaling kinases, which are essential for trans-
mitting signals in eukaryotes. EGCG and catechin gallate block the activity of LF, preventing 
MAPK-kinases cleavage and macrophages death [40]. In the case of EGCG, it also delays the 
death of mice exposed to the anthrax toxin [40]. It is noteworthy that although other catechins 
were evaluated, the presence of a galloyl group in the structure seems to be essential for this 
anti-virulence activity.
For the case of catechin (Figure 2B), it has also been reported that it inhibits the production of 
virulence factors regulated by QS in P. aeruginosa, such as pyocyanin and elastase [41]. Also, 
it was found to have a negative impact on the transcription of several genes involved in QS, 
such as those codifying proteins involved in the synthesis of autoinducer molecules [41].
Dental plaque is a complex biofilm that allows the survival and development of Streptococcus 
mutans. It has been reported that EGCG shows bactericidal activity against S. mutans; in addi-
tion, its antibiofilm activity is due to reducing the adherence of bacteria to surfaces by direct 
inhibition of glucosyltransferases [42], which are enzymes that synthesize polysaccharides 
[43, 44]. However, at sublethal concentrations, EGCG reduces biofilm by interfering with 
gene regulation, specifically by inhibiting the expression of the gtf genes (encoding glucosyl-
transferases), which are associated with adhesion and formation of biofilms [45]. Moreover, it 
represses genes encoding virulence factors associated with acidogenicity and acidurity, such 
as ldh, eno, dATP, Agud and the activity of the F₁F₀-ATPase and lactate dehydrogenase [42].
EGCG at sublethal concentrations also inhibits motility and biofilm formation of Campylobacter 
jejuni, a foodborne pathogen which is one of the main causes of gastrointestinal infections 
worldwide [46]. In this case, the mechanism involved in biofilm inhibition is related to QS 
inhibition [46].
It is worth noting that to date there are no studies to investigate its structure-activity rela-
tionship, so it is not yet known which parts of the structure are critical to their anti-virulence 
effects. However, for the (−) epicatechin (Figure 2D) which also possesses anti-QS activity 
Phenolic Compounds - Biological Activity144
against Chromobacterium violaceum, a Gram-negative bacteria with AHLs mediated QS [47]. 
The (−) epicatechin gallate (Figure 2E) at sublethal concentrations inhibits two of the major 
determinants of virulence in S. aureus, the α-toxin and the coagulase [48]. Furthermore, it 
has been shown that in combination with β-lactams, it is efficient to eliminate multiresistant 
strains of S. aureus. Although it has been observed that some synthetic analogs have better 
pharmacokinetic properties than the native (−) epicatechin gallate [49, 50].
2.2. Cinnamaldehyde and related compounds
Cinnamaldehyde (CN) (Figure 3A) is a major constituent of cinnamon essential oils and occurs 
naturally in the bark and leaves of cinnamon trees of the genus Cinnamomum [51]. The anti-
microbial activity of this compound has been proven [52, 53], but new studies have explored 
their anti-virulence properties, and in contrast to another compounds, it is considered a non-
toxic substance widely used in food and in the cosmetic industry and their use is generally 
recognized as safe [54].
In P. aeruginosa, the acylated homoserine lactones (AHLs) are their main autoinducer mole-
cules (Figure 1A) and the CN can inhibit their synthesis as well as the production of the phen-
Figure 3. Cinnamaldehyde and related compounds with anti-virulence properties. A: Cinnamaldehyde, B: 2-nitro-
cinnamaldehyde, C: 4-methoxy-cinnamaldehyde, D: 3,4-dichloro-cinnamaldehyde, E: (E)-4-phenyl-3-buten-2-one, F: 
(E)-3-decen-2-one, G: 4N-4-nitrocinnamaldehyde, H: 4D-4-dimethylaminocinnamaldehyde, I: caffeic acid, J: ferulic acid, 
K: p-coumaric acid, L: TS027, M: TS110, N: 4-methoxy-cinnamic acid, O: trans-2-methoxy-cinnamic acid.
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azine, pyocyanin and swarming motility [55]. Remarkably, CN also has antitoxin production 
and anti-hemolytic activities [56]. Similarly, in C. violaceum, Yersinia entrerolitica and Erwinia 
carotovora, the concentration of AHLs was also reduced by CN and the mechanism proposed 
was the inhibition of synthesis or degradation transformation of the autoinducer [57].
The antibiofilm properties of CN have been widely documented; for example, in P. aerugi-
nosa and in enterohemorrhagic Escherichia coli, this compound markedly abolished the bio-
film formation in a dose-dependent manner by reducing the swarming motility and fimbriae 
production, respectively. In a previous report, it was shown that for the uropathogenic E. coli, 
CN prevented biofilm formation on plates and catheters, furthermore effectively inactivated 
preformed biofilms [54]. The mechanism proposed for the biofilm inhibition was related to 
the hydrophobicity of this compound, which helps to target lipids located in the bacterial cell 
membrane and mitochondria, increasing the membrane permeability, leading to the leakage 
of ions and other cell contents [54, 58]. The foodborne pathogen Listeria monocytogenes forms 
biofilm for persistence and survives in which CN has inhibitory effect on formation and inac-
tivating mature biofilm by means of the down-regulated critical genes for biofilm formation 
in this bacteria [59].
In Vibrio harveyi, the autoinducer-2 (A2) is also blocked by CN in a concentration-dependent 
way by decreasing the binding ability of the autoinducer to its response regulator protein. 
Between cinnamaldehyde derivatives, the 2-nitro-cinnamaldehyde (Figure 3B) was the most 
active compound yielding an inhibition of A2 similar to CN [60]. Similarly, the 2-nitro-cinna-
maldehyde and 4-methoxy-cinnamaldehyde (Figure 3C) inhibit pigment production and prote-
ase activity in Vibrio anguillarum [60]. The CN is an aromatic carboxylic acid, and its inhibitory 
was highly dependent on the substitution pattern of the aromatic ring. Replacement of the 
dimethylamine (Me
2
N) substituent with a methoxy (MeO) or a nitro (NO
2
) group enhanced 
the activity [60].
Various cinnamaldehyde analogs were also evaluated against Vibrio spp. The most active com-
pounds were 2-nitro-cinnamaldehyde, 3, 4-dichloro-cinnamaldehyde (Figure 3D), (E)-4-phenyl-3-
buten-2-one (Figure 3E) and (E)-3-decen-2-one (Figure 3F), which show inhibitory activity in 
A2, bioluminescence, pigment and protease production [61]. In this case, also the inhibitory 
effect of cinnamaldehyde analogs was dependent on the structure, and analogs in which the 
aromatic ring was replaced by an alkyl moiety, but which still contain the acrolein group, 
proved also to be active inhibitors [61]. In general, the inhibitory effect of cinnamaldehyde 
analogs is highly dependent on the nature and degree of substitution of the aromatic ring, and 
the substituents with electron-withdrawing properties increase its activity. The CN and their 
analogs furthermore proved to be active blockers of virulence in vivo in different models, sug-
gesting that they may have potential for therapeutic applications in humans and animals [61].
The CN also has inhibitory activity on biofilm formation in a methicillin-resistant Staphylococcus 
aureus at dose-dependent manner and represses the expression of sarA, a gene implicated in the 
regulation of its biofilm [51]. In Streptococcus pyogenes, when the biofilm was treated with CN 
and their derivatives the 2-nitro-cinnamaldehyde (Figure 3B), 4N-4-nitrocinnamaldehyde (Figure 
3G) and 4D-4-dimethylaminocinnamaldehyde (Figure 3H), the biomass, average thickness and 
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colony size at substratum were decreased and the molecular docking shows sequence and 
structure similarity with the active site for QS inhibition [62].
Among the cinnamaldehyde-related molecules, the caffeic acid (CA) (Figure 3I) and ferulic acid 
(FA) (Figure 3J) have shown antibiofilm properties. CA is the first phenolic acid compound 
that has been reported to have inhibitory activity on biofilm formation in Staphylococcus epi-
dermis by a mechanism that did not involve bacterial death [63]. The potential of FA to control 
biofilm formation has been demonstrated by the reduction in mass and metabolic activity in 
Escherichia coli and Listeria monocytogenes biofilms, and also this compound caused the total 
inhibition of motility in both bacteria and the colony spreading in S. aureus; a form of passive 
bacterial movement was also inhibited [64].
The QS inhibitory activity of CA and FA also was evaluated in C. violaceum, and the results 
revealed that the activity was mediated by their ability to modulate AHL activity and syn-
thesis [47]. Other related compound the p-coumaric acid (Figure 3K) showed QS inhibition in 
reporter strains like C. violaceum, Agrobacterium tumefaciens and Pseudomonas chlororaphis [65]. 
In addition, it represses the expression of regulatory genes of the T3SS of the phytopatho-
genic bacteria Dickeya dadantti, and for this activity, its hydroxyl group on the phenyl ring 
and the double bond are important [66]. Some of their derivatives such as TS027 (Figure 3L) 
and TS110 (Figure 3M) also repress the expression of T3SS regulatory genes and inhibit T3 
effector protein in P. aeruginosa without affecting its growth [67]. While the cinnamic acid 
and 4-methoxy-cinnamic acid (Figure 3N) suppress the expression of T3SS in Erwinia amylovora 
[68], the o-coumaric acid (isomer of 3M) and trans-2-methoxy-cinnamic acid (Figure 3O) suppress 
translocation of two effector proteins of T3SS in Xanthomonas oryzae [69].
2.3. Coumarin and related compounds
The coumarins are compounds that have caused great interest for their pharmacological 
properties such as anti-inflammatory, antitumor, antioxidant and bactericidal activity [70]. 
Moreover, recently it has also documented that they possess anti-virulence properties. The 
coumarin (Figure 4A) and umbelliferone (Figure 4B) inhibit biofilm formation of E. coli, without 
affecting its growth. By a transcriptional analysis, it was identified that these phenols act by 
repressing genes related to curli production and motility, which causes a decrease in the pro-
duction of fimbriae and swarming [71]. For these molecules, the hydroxylation of coumarin is 
an important determinant for their antibiofilm activity, since the position of hydroxyl groups 
as well as their number affects the antibiofilm compound activity [71].
Similarly, the presence of characteristic functional groups promotes the effective inhibition 
of virulence factors, as in the case of the furocoumarins [72], dihydroxybergamottin (Figure 4C) 
and bergamottin (Figure 4D), which exhibit anti-quorum-sensing effect on the AI-1 and AI-2 
systems in Vibrio harveyi. Similarly, these furocoumarins inhibit biofilm formation of E. coli, V. 
harveyi, Salmonella typhimurium and P. aeruginosa without affecting bacterial growth. Although 
their mechanism of action is unknown, it is suggested that the presence of a furan residue 
could be acting as a competitive inhibitor for binding with the receptor protein of natural 
bacterial autoinducers [72].
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2.4. Curcumin and related compounds
The major constituent of turmeric (Curcuma longa L.) roots/rhizomes is the curcumin (CUR) 
(Figure 5A), which is an active compound that showed an important antimicrobial activity 
[73, 74], but several studies also corroborate their inhibitory activity against virulence factors 
in pathogenic bacteria.
Figure 4. Coumarin and related compounds with anti-virulence properties. A: Coumarin, B: umbelliferone, C: 
dihydroxybergamottin, D: bergamottin.
Figure 5. Curcumin and related compounds with anti-virulence properties. A: Curcumin, B: demethoxycurcumin, C: 
bisdemethoxycurcumin.
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The secretion of sortase A (SrtA) a surface protein in S. aureus involved in bacterial adhesion 
for pathogenesis was inhibited by CUR, and also on in vivo assays, this compound reduces the 
capacity of bacteria to adhere to surfaces in a dose-dependent manner [75]. The other deriva-
tives present in turmeric extract are demethoxycurcumin (Figure 5B) and bisdemethoxycurcumin 
(Figure 5C), which show inhibitory activity of SrtA [75]. Similarly, in Streptococcus mutans 
CUR inhibited the activity of SrtA and other proteins implicated in bacterial adhesion reduc-
ing the biofilm formation in this bacteria [76, 77]. The diverse biological properties of CUR 
and its derivatives are attributed to the hydroxyl and phenol groups in the molecule [78], and 
structure-activity relationship studies suggest that a hydroxy group at the para-position is 
most critical for the expression of biological activity in these compounds [79].
The antibiofilm activity of CUR against uropathogens such as E. coli, Proteus mirabilis and 
Serratia marcescens was evaluated, and the results showed that their biofilm maturation was 
disturbed by a biomass reduction and by the interruption of swimming motility [80]. In clini-
cal isolates of Klebsiella pneumoniae, the treatment with CUR was also effective for biofilm 
inhibition [81] as well in enterohemorrhagic E. coli [82]. In the same way, in Vibrio spp. the 
inhibitory effect on biofilm formation with the CUR treatment depends on the disruption of 
the maturation of biofilms and in the reduction of swimming and swarming motility. Further, 
this compound significantly represses other virulence factors like alginate and exopolysac-
charide production and also inhibits bioluminescence. These inhibitory effects were also 
demonstrated on in vivo models in which CUR enhanced the survival rate of Artemia nauplii 
against Vibrio harveyi [83].
Diverse virulence factors in P. aeruginosa were inhibited by CUR, specifically the elastase, 
protease and pyocyanin production without affecting bacterial growth in a dose-dependent 
manner. The biofilm inhibition effect was demonstrated in vivo using Arabidopsis thaliana, 
where the treatment with CUR caused a reduction in the plant mortality by suppressing bio-
film formation [84]. In the pathogenicity model using Caenorhabditis elegans, CUR demonstrate 
their anti-infective properties by reducing the nematode mortality [84]. Additionally, in P. 
aeruginosa and C. violaceum, CUR showed an anti-quorum sensing activity by inhibiting the 
production of acyl homoserine lactones [84].
2.5. Eugenol and related compounds
Eugenol (EG) (Figure 6A) is a major component of clove oil that possesses various biological 
properties [85], and their anti-virulence activity also has been evaluated. In pathogenic bacte-
ria that secreted a broad spectrum of virulence factors that contribute to their  pathogenicity, 
Figure 6. Eugenol and related compounds with anti-virulence properties. A: Eugenol, B: eugenyl acetate, C: isoeugenol, 
D: methyl eugenol.
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EG showed inhibitory activity. For example, in the nosocomial pathogen S. aureus, the hemo-
lysin, staphyloxanthin, toxic shock syndrome toxin 1 (TSST-1) and enterotoxins are the most 
important virulence factors that were remarkably affected by EG [85]. The expression of vir-
ulence-related genes (sea, seb, tst and hla) was also decreased after the treatment with this 
compound [85].
In a methicillin-resistant (MRSA) and methicillin-sensitive (MSSA) S. aureus at subinhibitory 
concentration, EG eradicates pre-established biofilms and inhibited the colonization of this 
bacteria in a rat middle ear model, decreasing biofilm in biomass, cell viability and the expres-
sion of biofilm-related genes (icaD, sarA and seA), resulting in a low accumulation of polysac-
charides and poorly adhesion of cells within biofilms [86]. The biofilm eradication effect of 
EG was mediated by two mechanisms: bacterial lysis within biofilms and by the disruption of 
cell-to-cell connections, hence dismantling the biofilm organization, which can be attributed 
to the hydrophobic and the lipophilic nature of their chemical structure [86].
The biofilm formation and biofilm-related genes in L. monocytogenes and E. coli also were 
inhibited by EG at dose-dependent manner [56, 59]. In P. aeruginosa, although EG was unable 
to inhibit biofilm formation, it markedly reduced the production of pyocyanin, fimbriae pro-
duction, hemolytic activity and other QS-controlled virulence factors in this bacterium such 
as the pseudomonas quinolone signal (PQS) [56]. Other study showed that EG at subinhibi-
tory concentrations has QS inhibitory activity in P. aeruginosa and C. violaceum [87].
Moreover, derivatives of EG eugenyl acetate (EA) (Figure 6B), isoeugenol (IE) (Figure 6C) and 
methyl eugenol (ME) (Figure 6D) showed anti-virulence properties against pathogenic bacte-
ria. In S. aureus, EA inhibited the production of virulence factors like hemolysin and staphy-
loxanthin. Similarly, in P. aeruginosa the pyocyanin, pyoverdin and exoprotease production 
were significantly reduced after the treatment with EA, and it also exhibited QS inhibitory 
potential in C. violaceum [88]. The other derivatives, IE and ME, also presented QS inhibitory 
against P. aeruginosa and C. violaceum [89, 90], and in the case of V. harveyi, ME have anti-bio-
luminescence activity [90]. These anti-virulence properties can be attributable to the presence 
of numerous substituted aromatic molecules like in the case of other phenols [85].
2.6. Long-chain phenols
Long-chain phenols are a group of metabolites which have extensively studied antitumor, 
antimicrobial and antioxidant activities; they are also of great interest to the industry because 
they are used to manufacture different chemicals [91]. Also, different long-chain phenols 
reported have different anti-virulence properties.
Our research group identified a mixture of four anacardic acids (AA) capable of inhibiting 
QS in C. violaceum and also able to reduce the production of virulence factors such as pyo-
cyanin, rhamnolipids and elastase activity in P. aeruginosa [92]. Similarly, another mixture 
of AA (Figure 7A) and one of cardanols (Figure 7B) was capable of inhibiting P. aeruginosa 
biofilms. Notably, although the antibiofilm mechanism is not known, the polymerization of 
the AA (Figure 7C) slightly potentiates the activity [36]. Similarly, the maximum antibiofilm 
activity observed for this phenol was around 80% inhibition, which is reduced to 50% by the 
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presence of a carboxyl group (salicylic acid) and only increases with the addition of an alkyl 
chain [36]. Hence, the incorporation of different types of alkyl chain in the meta-position 
of the salicylic acid seems to play a role in its activity, but this needs to be investigated in 
more detail.
Similarly, the antibiofilm activity of gingolic acids was reported, specifically the C15:1 (Figure 7D) 
abolished biofilm production without affecting bacterial viability, as well as reduced fimbriae 
production in enterohemorrhagic E. coli [93]. Transcriptomic analysis by DNA microarrays 
and qRT-PCR demonstrated that C15: 1 represses expression of genes involved in the synthe-
sis of curli [93].
Figure 7. Long-chain phenols with anti-virulence properties. A: Anacardic acid mixture, B: cardanol mixture, C: 
polyanacardic acid, D: ginkgolic acids C15:1, E: 6-oxa isosteres of anacardic acids.
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Furthermore, although mixtures of such compounds have shown anti-virulence activity, 
separation is laborious and costly, so their chemical syntheses become an attractive alterna-
tive. In this regard, AA synthetic (6-oxa isosteres) C: 11-C: 16 (Figure 7E) showed inhibition 
of TCS (KinA/SpoOF and NRII/NRI) [94]. Interestingly, AA with alkyl chains outside this 
range are not active [94]. Likewise, for this activity, the presence of the carboxyl group is 
important, as the C:12 and C:14 completely lose their effect, and the presence of phenolic OH 
partially restores it. Long-chain phenols are a group of natural products with great structural 
diversity, which represent an important potential source of molecules with anti-virulence 
activity.
2.7. Quercetin and related compounds
Various biological activities including anti-cancer, antibacterial, hepatoprotective, anti-
inflammatory and antiviral activities have been attributed to flavonoids [95]; moreover, recent 
studies have shown that various flavonoids also have anti-virulence activity.
Flavonoids like flavone (Figure 8A), quercetin (Figure 8B), apigenin (Figure 8C) and fisetin 
(Figure 8D) decrease blood hemolysis induced by S. aureus. Specifically, for flavone it was 
elucidated that its activity is due the repression of the transcription of α-hemolysin genes (hla) 
and the global regulator gene (Sae) [96].
In addition, antibiofilm activity in S. aureus by quercetin (Figure 8B), chrysin (Figure 8E), api-
genin (Figure 8C), kaempferol (Figure 8F) and fisetin (Figure 8D) has been reported where the 
number of hydroxyls is directly related to the increase in the activity [97], whereas morin 
(Figure 8G), myricetin (Figure 8H), quercetin (Figure 8B) and kaempferol (Figure 8F), having 
a hydroxyl group at C-2´ and C-4´ in ring B, inhibit SrtA and SrtB sortases of S. aureus more 
effectively [98].
The myricetin (Figure 8H) is a compound able to interact with listeriolysin O, a virulence fac-
tor of Listeria monocytogenes that is involved in the lysis of host cells. This interaction is related 
to the presence of the double bond in the molecule, specifically in the C1-C2 position in ring 
C [99]. This generates a complex that blocks the hemolytic activity of the listeriolysin as it 
prevents binding to cholesterol.
Furthermore, it has been shown that the naringenin (Figure 8I) have antibiofilm activity on 
V. harveyi and E. coli; however, this activity is compromised when sugar residues are incor-
porated [100]. In the case of V. harveyi, the naringenin also represses the expression of T3SS 
regulatory genes [100].
2.8. Resveratrol and related compounds
Resveratrol (RV) (Figure 9A) is a natural polyphenol and phytoalexin produced by plants in 
case of attacks by pathogens [101]. It is mainly found in the skin of grapes, some berries and 
red wine [102]. For its medical properties, it is recognized as a compound that provides mul-
tiple benefits to human health [103] and recent studies have demonstrated its anti-virulence 
potential.
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Since plants produce RV, this metabolite was identified as the active compound with inhibi-
tory activity against biofilm formation in Propionibacterium acnes from extracts of plants used 
in traditional Chinese medicine [104]. Also in S. aureus, the evaluation of different commercial 
red wines showed a dose-dependent inhibition of biofilm formation, hemolytic activity and 
increase in the survival of Caenorhabditis elegans exposed to the bacteria [97]. One of the major 
constituents of these red wines was RV, and similarly, it inhibited hemolysis in S. aureus [97]. 
In Vibrio cholerae, the biofilm formation has a prominent role in pathogenesis and RV was 
found to be a potent biofilm inhibitor at subinhibitory concentrations and showed binding 
affinity with the virulence activator AphB [102]. Furthermore, in the uropathogenic bacteria, 
Proteus mirabilis RV inhibited swarming motility, hemolysin and urease activity as well as the 
virulence factor expression at dose-dependent manner [101].
Compounds related to RV, the oxyresveratrol (Figure 9B), dicinnamyl (Figure 9C), cis-stilbene 
(Figure 9D) and trans-stilbene (Figure 9E) also were evaluated against S. aureus virulence. 
Figure 8. Quercetin and related compounds with anti-virulence properties. A: Flavone, B: quercetin, C: apigenin, D: 
fisetin, E: chrysin, F: kaempferol, G: morin, H: myricetin, I: naringenin.
Phenolic Compounds with Anti-virulence Properties
http://dx.doi.org/10.5772/66367
153
Only, the cis-stilbene and trans-stilbene along with RV markedly inhibited the hemolytic activ-
ity by more than 80%, while dicinnamyl, oxyresveratrol and trans-stilbene have a significant bio-
film inhibition effect [105]. The inhibitory activity of trans-stilbene was corroborated with the 
evidence that is able to repress the expression of the α-hemolysin gene (hla) and of genes 
implicated in adhesion (icaA and icaD) and with the attenuation of S. aureus virulence in the 
nematode C. elegans [105]. In enterohemorrhagic E. coli, the RV isolated from the extract of 
Carex dimorpholepis significantly reduced biofilm formation (up to 90%), expression of biofilm-
related genes and swimming and swarming motilities, suggesting that this compound is a 
major antibiofilm component in this extract, corroborating its potential as therapeutic agent 
against E. coli [106].
The RV and its oligomers, namely ε-viniferin (Figure 9F), suffruticosol A (Figure 9G), suffruti-
cosol B (Figure 9H), vitisin A (Figure 9I) and vitisin B (Figure 9J) isolated from different plant 
families, also have antibiofilm activities against E. coli. The qRT-PCR analyses showed that 
ε-viniferin, suffruticosol B and vitisin B repress the expression of genes involved in curli and 
fimbriae production [105]. Also, RV and suffruticosol A, suffruticosol B, vitisin A and B inhibit 
biofilm formation in P. aeruginosa at dose-dependent manner [106].
The oligomers ε-viniferin and trans-gnetin (Figure 9K) isolated from Paeonia lactiflora have inhib-
itory activity in neuraminidase activity, an enzyme involved in many pathological  process in 
Figure 9. Resveratrol and related compounds with anti-virulence properties. A: Resveratrol, B: oxyresveratrol, C: 
dicinnamyl, D: cis-stilbene, E: trans-stilbene, F: ε-viniferin, G: suffruticosol A, H: suffruticosol B, I: vitisin A, J: vitisin B, 
and K: trans-gnetin.
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tropical human pathogens [107]. Furthermore, the ε-viniferin and RV isolated from Carex pumila 
extract also demonstrated significantly biofilm inhibition in P. aeruginosa and E. coli [108]. The 
anti-quorum sensing activity of RV also was demonstrated, in C. violaceum, since it reduces vio-
lacein production [57, 109]. In Yersinia enterolitica and Erwinia amylovora, it was one of the most 
active compounds that can reduce the concentration of the autoinducers due to degradation 
transformation or inhibition of synthesis [57].
2.9. Salicylic acid and related compounds
Salicylic acid (SA) (Figure 10A) is a phenolic compound synthesized by plants that play an 
important role in the regulation of various physiological processes [110, 111], and in recent 
years, their inhibitory activity against bacterial virulence has been reported.
Several studies have demonstrated that SA has inhibitory activity in the motility and pro-
duction of extracellular virulence factors in the opportunistic pathogenic bacteria P. aerugi-
nosa, and among those factors, pyocyanin was inhibited by approximately 80% by SA and 
decreased the elastase and exoprotease production [110]. Similarly, a subinhibitory concen-
Figure 10. Salicylic acid and related compounds with anti-virulence properties. A: Salicylic acid, B: acetyl salicylic acid, 
C: salicylamide, D: methyl salicylate, E: benzoic acid, F: p-hydroxybenzoic acid, G: protocatechuic acid, H: vanillic acid, 
I: gallic acid.
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tration of SA inhibited the twitching and swimming motility as well as the invasion and acute 
cytotoxicity of P. aeruginosa in corneal epithelial cells [112]. Some derivatives of SA, including 
acetyl salicylic acid (Figure 10B), salicylamide (Figure 10C), methyl salicylate (Figure 10D) and a 
precursor of SA, benzoic acid (Figure 10E), were evaluated, and the inhibition levels observed 
were comparable with those obtained with SA for the same virulence factors [110]. SA is a 
benzoic acid that possesses an aromatic ring bearing a hydroxyl group, and probably, one of 
these components of the structure is responsible for its anti-virulence activity.
The biofilm formation in P. aeruginosa was also inhibited by SA in vitro and in vivo decreas-
ing the attachment and consequently the biofilm formation [36, 110]. Similarly, in other 
bacterial pathogenic species that form biofilms, SA has inhibitory activity; for example, in 
Streptococus mutans, the biofilm formation was highly decreased when the enzymes, gluco-
syl and fructosyl transferases, which synthetize extracellular polymeric substances, were 
inhibited by SA [113].
Compounds related to SA, the p-hydroxybenzoic acid (Figure 10F) and protocatechuic acid 
(Figure 10G) at growth subinhibitory concentrations have different modes of action on biofilm 
formation disruption in Staphylococcus species [114]. Also, for the bacteria Helicobacter pylori 
implicated in the development of peptic ulcer, duodenal ulcer and gastric cancer, which uses a 
urease enzyme for the basification of the stomach pH and hence the colonization of the gastric 
mucosa [115], the protocatechuic acid has an inhibitory effect of 40% in its urease activity [116]. 
Vanillic acid (4-hydroxy-3-methoxybenzaldehyde) (Figure 10H) also showed antibiofilm activ-
ity in Aeromonas hydrophila at all the concentrations used in the range of 0–0.250 mg/mL [117].
Other important hydroxy benzoic acid with a numerous reports of anti-virulence proper-
ties is gallic acid (GA) (Figure 10I), which shows inhibition in many virulence factors among 
bacteria. For example, in S. aureus, GA reduces the bacterial adhesion and biofilm formation 
as well as the production of α-hemolysin a virulence factor produced by the bacteria with 
hemolytic, cytotoxic, dermonecrotic and lethal properties [118] since its activity was inhibited 
in a dose-dependent manner by this compound [119]. Similarly, in P. aeruginosa, E. coli and 
Listeria monocytogenes, their biofilm formation was also inhibited by GA.
The inhibitory activity showed by these compounds may be related to some of their structural 
features, since different reports mentioned that in the active phenolic compounds, the basic skel-
eton remains the same, the basic skeleton remains same, but the number and positions of the 
hydroxyl groups on the aromatic ring and the type of substituents provide different biological 
properties [120–122]. Also, SA, gallic acid and vanillic acid have QS inhibitory activity by two differ-
ent mechanisms: first, by affecting the synthesis of AHLs [55, 57, 123] and second, by interfering 
with the binding of short-chain AHLs to their receptor, especially in the case of vanillic acid [117].
3. Conclusion and future perspective
An important feature of the anti-virulence molecules is that they may be less prone to pro-
mote the emergence of resistance than conventional antibiotics. At the moment, phenolic 
compounds represent the largest number of natural products with anti-virulence-reported 
activity and whose main target has been the inhibition of QS and biofilms. However, it has 
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also been found that they can directly inhibit some of virulence factors such as sortases, curli, 
type III secretion system (T3SS), fimbriaes and two-component regulatory systems. It should 
be noted that most of the phenolic compounds represent structures already known, several of 
which have been subject to different pharmacological studies and some are even part of the 
international pharmacopeia and are active ingredients of herbal medicines.
Moreover, although QS is considered the main regulator of bacterial virulence, this is still 
part of a complex network of interconnected components including several environmental 
regulation systems and QS-independent virulence factors. Also, the direct inhibition of viru-
lence factors and regulators of QS and TCS represents interesting options for achieving the 
implementation of this strategy. Thus, the correct design of anti-virulence therapies is very 
important [124, 125], and a feasible option is the combination of drugs with different action 
targets. In the same way, some challenges to overcome involve the evaluation of anti-vir-
ulence compounds in most bacterial systems, the corroboration in vivo in animal infection 
models and finally the evaluation of possible side effects on the populations of commensal 
and symbiotic bacteria.
Given the growing public health problem worldwide derived by the emergence of bacte-
rial multiresistance to antibiotics, the development of suitable anti-virulence therapies is pre-
sented as a viable strategy to provide a solution to this problem; moreover, we are in the 
decisive years that will dictate the implementation of these kind of strategies, this is occurring 
in a period of resurgence of the interest in natural products activities in which phenolic com-
pounds have a fundamental role.
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